Skip Navigation

JNCI Journal of the National Cancer Institute 2007 99(10):741; doi:10.1093/jnci/djk215
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Japanese Translation
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2007.

IN THIS ISSUE

The first 10% of the full text of this article appears below.

Multivitamin Supplement Use and Prostate Cancer Risk

An estimated 35% of adults in the United States take multivitamin supplements. Lawson et al. (p. 754) used a questionnaire to collect data on multivitamin/multimineral supplement use from almost 300,000 AARP members and then assessed the association between supplement use in men and the risk of localized and advanced prostate cancer. Multivitamin supplement use did not appear to be associated with the overall risk of prostate cancer. However, an increased risk of advanced prostate cancer was observed among the heaviest users (>7 times per week) compared with those who did not take . . . [Full Text of this Article]

Bisphosphonate Treatment and Locally Advanced Prostate Cancer

Alcohol, Tobacco Use, and Head and Neck Cancer Risk

Second Cancer Risk in Childhood Leukemia and Lymphoma Survivors

Alcohol Intake and Decreased Risk of Kidney Cancer

FLIP, Cell Death through Anoikis, and Tumor Metastasis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

Surviving Antioxidant Supplements
Goran Bjelakovic and Christian Gluud
J Natl Cancer Inst 2007 99: 742-743. [Extract] [Full Text] [PDF]

The If's, And's, or But's Regarding Bisphosphonates for Prostate Cancer
Timothy J. Wilt and Kristine E. Ensrud
J Natl Cancer Inst 2007 99: 744-745. [Extract] [Full Text] [PDF]

Multivitamin Use and Risk of Prostate Cancer in the National Institutes of Health–AARP Diet and Health Study
Karla A. Lawson, Margaret E. Wright, Amy Subar, Traci Mouw, Albert Hollenbeck, Arthur Schatzkin, and Michael F. Leitzmann
J Natl Cancer Inst 2007 99: 754-764. [Abstract] [Full Text] [PDF]

Oral Sodium Clodronate for Nonmetastatic Prostate Cancer—Results of a Randomized Double-Blind Placebo-Controlled Trial: Medical Research Council PR04 (ISRCTN61384873)
Malcolm D. Mason, Matthew R. Sydes, John Glaholm, Ruth E. Langley, Robert A. Huddart, Michael Sokal, Mark Stott, Anne C. Robinson, Nicholas D. James, Mahesh K. B. Parmar, and David P. Dearnaley
J Natl Cancer Inst 2007 99: 765-776. [Abstract] [Full Text] [PDF]

Alcohol Drinking in Never Users of Tobacco, Cigarette Smoking in Never Drinkers, and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium
Mia Hashibe, Paul Brennan, Simone Benhamou, Xavier Castellsague, Chu Chen, Maria Paula Curado, Luigino Dal Maso, Alexander W. Daudt, Eleonora Fabianova, Victor Wünsch-Filho, Silvia Franceschi, Richard B. Hayes, Rolando Herrero, Sergio Koifman, Carlo La Vecchia, Philip Lazarus, Fabio Levi, Dana Mates, Elena Matos, Ana Menezes, Joshua Muscat, Jose Eluf-Neto, Andrew F. Olshan, Peter Rudnai, Stephen M. Schwartz, Elaine Smith, Erich M. Sturgis, Neonilia Szeszenia-Dabrowska, Renato Talamini, Qingyi Wei, Deborah M. Winn, David Zaridze, Witold Zatonski, Zuo-Feng Zhang, Julien Berthiller, and Paolo Boffetta
J Natl Cancer Inst 2007 99: 777-789. [Abstract] [Full Text] [PDF]

Risk of Second Malignant Neoplasms After Childhood Leukemia and Lymphoma: An International Study
Milena Maule, Ghislaine Scélo, Guido Pastore, Paul Brennan, Kari Hemminki, Elizabeth Tracey, Risto Sankila, Elisabete Weiderpass, Jorgen H. Olsen, Mary L. McBride, David H. Brewster, Vera Pompe-Kirn, Erich V. Kliewer, Kee Seng Chia, Jon M. Tonita, Carmen Martos, Jon G. Jonasson, Franco Merletti, and Paolo Boffetta
J Natl Cancer Inst 2007 99: 790-800. [Abstract] [Full Text] [PDF]

Alcohol Intake and Renal Cell Cancer in a Pooled Analysis of 12 Prospective Studies
Jung Eun Lee, David J. Hunter, Donna Spiegelman, Hans-Olov Adami, Demetrius Albanes, Leslie Bernstein, Piet A. van den Brandt, Julie E. Buring, Eunyoung Cho, Aaron R. Folsom, Jo L. Freudenheim, Edward Giovannucci, Saxon Graham, Pamela L. Horn-Ross, Michael F. Leitzmann, Marjorie L. McCullough, Anthony B. Miller, Alexander S. Parker, Carmen Rodriguez, Thomas E. Rohan, Arthur Schatzkin, Leo J. Schouten, Mikko Virtanen, Walter C. Willett, Alicja Wolk, Shumin M. Zhang, and Stephanie A. Smith-Warner
J Natl Cancer Inst 2007 99: 801-810. [Abstract] [Full Text] [PDF]

Critical Role for Fas-Associated Death Domain–Like Interleukin-1–Converting Enzyme–Like Inhibitory Protein in Anoikis Resistance and Distant Tumor Formation
Imtiaz A. Mawji, Craig D. Simpson, Rose Hurren, Marcela Gronda, Moyo A. Williams, Jorge Filmus, James Jonkman, Ralph S. Da Costa, Brian C. Wilson, Michael P. Thomas, John C. Reed, Gennadi V. Glinsky, and Aaron D. Schimmer
J Natl Cancer Inst 2007 99: 811-822. [Abstract] [Full Text] [PDF]